02 Aug Aegis receives Distinguished Abstract recognition
The study, Evidence of Missed Novel Psychoactive Substances (NPS) in Unexpected Fentanyl Positives, by Aegis Sciences Corporation was recognized by the AACC Annual Scientific Meeting & Clinical Lab Expo.
Each year, a group of Academy fellows reviews the abstracts submitted to the AACC Annual Scientific Meeting & Clinical Lab Expo and selects several for distinction. The study evaluated how common novel psychoactive substances are in fentanyl tests and found that out of 200 urine and oral fluid samples gathered from individuals who tested positive for fentanyl, more than half tested positive for at least one novel psychoactive substance that can heighten the drug’s danger.
To read the full abstract please visit: https://www.abstractsonline.com/pp8/#!/10910/presentation/727
